Robert Guice Net Worth

What's Robert Guice's mailing address?

Robert's mailing address filed with the SEC is 28161 N. KEITH DRIVE, , LAKE FOREST, IL, 60045.

Insiders trading at Stericycle

Over the last 22 years, insiders at Stericycle have traded over $161,740,081 worth of Stericycle stock and bought 27,280 units worth $1,574,920 . The most active insiders traders include Jack W Schuler, John Connaughton, eJames Reid Anderson. On average, Stericycle executives and independent directors trade stock every 23 days with the average trade being worth of $835,752. The most recent stock trade was executed by Jesse Joel Jr Hackney on 16 May 2024, trading 3,620 units of SRCL stock currently worth $223,245.

What does Stericycle do?

stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to

Stericycle executives and stock owners

Stericycle executives and other stock owners filed with the SEC include:

• Cindy Miller,
  President, Chief Executive Officer, Director
• Cindy J. Miller,
  Pres, CEO & Director
• Janet H. Zelenka,
  Exec. VP, CFO & Chief Information Officer
• Daniel Ginnetti,
  Executive Vice President - International
• Janet Zelenka,
  Chief Financial Officer, Executive Vice President, Chief Information Officer
• Kurt Rogers,
  Executive Vice President, General Counsel and Corporate Secretary
• Joseph Reuter,
  Executive Vice President and Chief People Officer
• Stephen Cory White,
  Exec. VP & Chief Commercial Officer
• Kurt M. Rogers,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Robert Murley,
  Independent Chairman of the Board
• Brian Anderson,
  Independent Director
• Lynn Bleil,
  Independent Director
• Michael Zafirovski,
  Independent Director
• Kay Priestly,
  Independent Director
• Veronica Hagen,
  Independent Director
• Thomas Chen,
  Independent Director
• J. Joel Hackney,
  Independent Director
• Stephen Hooley,
  Independent Director
• S. Cory White,
  Executive Vice President and Chief Commercial Officer
• Richard Moore,
  Executive Vice President - North American Operations
• Dominic Culotta,
  Executive Vice President and Chief Engineer
• Michael Weisman,
  Executive Vice President, Chief Ethics and Compliance Officer
• Richard Michael Moore,
  Exec. VP of North American Operations
• Joseph Anthony Reuter,
  Exec. VP & Chief People Officer
• Michael S. Weisman,
  Exec. VP and Chief Ethics & Compliance Officer
• Andrew Ellis,
  VP of Investor Relations
• Daniel V. Ginnetti,
  Exec. VP of International
• Jennifer Koenig,
  VP of Corp. Communications & Investor Relations
• Richard Joseph Hoffman,
  Sr. VP & Chief Accounting Officer
• Richard J Hoffman,
  SVP & CHIEF ACCOUNTING OFFICER
• John P Schetz,
  Sr Counsel M & A
• Thomas D Brown,
  Director
• Mike S Zafirovski,
  Director
• John Patience,
  Director
• Jack W Schuler,
  Chairman
• Brenda R Frank,
  EVP & Chief People Officer
• Brent Arnold,
  President, USA/Canada
• Ruth Ellen Abdulmassih,
  Executive Vice President
• Rodney F Dammeyer,
  Director
• Charles A Alutto,
  President, USA
• Robert Guice,
  Executive Vice President, Intl
• David W. Stahl,
  EVP and CIO
• William J. Seward,
  EVP, Chief Commercial Officer
• James Reid Anderson,
  Director
• Mark C Miller,
  CEO
• Michael J Collins,
  President, Pharma Services
• Shan Sacranie,
  Exec Vice Pres International
• Richard L Foss,
  EXVP
• Richard T Kogler,
  COO
• Richard J Marasco,
  Exec VP Corp Mergers & Acquis
• Thomas R Reusche,
  Director
• L John Wilkerson,
  Director
• Jonathan T Md Lord,
  Director
• Peter Vardy,
  Director
• Brink Frank Jm Ten,
  CFO
• William K Hall,
  Director
• Ronald G Spaeth,
  Director
• Patrick F Graham,
  Director
• Anthony J Tomasello,
  Vice President
• James J Martell,
  Director
• John Connaughton,
  Director
• James L Welch,
  
• Victoria L Dolan,
  
• Naren K Gursahaney,